NCT00285077 - Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease | Biotech Hunter

Enrollment

390

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Alzheimer Disease

Interventions

DRUG

SR57667B

Trial Locations (7)

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Horslholm

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Bromma